TORONTO, July 11, 2019 /CNW/ - Namaste Technologies Inc. ("Namaste" or the "Company") (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) today announced that it has signed an agreement with 2103486 Alberta Ltd. operating as "ARBR" to incorporate NamasteMD into the ARBR clinical referral platform. ARBR is a web-based tool developed to help pharmacists and clinicians guide patients through their cannabis journey and support patients with questions or concerns, allowing them to select the right strain for their individual needs. The Edmonton, AB-based company has an agreement with one of Canada's largest generic pharmaceutical manufacturers whose customers include over 11,000 pharmacies across Canada.
Based on the agreement with ARBR, NamasteMD will act as a direct-connect telemedicine application to allow patients to immediately transition from the pharmacist's or clinician's consultation to a connection with a medical professional. Under the terms of the agreement, CannMart will be a preferred marketplace of choice given its large selection of LPs, strains, and other products.
"We continue to find innovative ways to expand our network and build the world's most customer focused cannabis marketplace," said Meni Morim, Interim CEO at Namaste Technologies. "We're leveraging in-house developed technology, like NamasteMD, to support tools like ARBR. This relationship opens a new channel to medical cannabis patients and allows the adult-use cannabis consumer to utilize their existing pharmacy relationships."
"Our goal is to provide a seamless transition from consulting a pharmacist about your cannabis needs, to being able to get a medical document and order product near instantaneously; with the added benefit of the largest selection of product possible," added Morim. "This agreement with a leading technology platform like ARBR continues to demonstrate our unique approach to the cannabis market and will help accelerate our growth."
"NamasteMD and the CannMart platform are a great way for pharmacists using our ARBR cannabis application to connect their customers with medical professionals and help service their customers' needs," said Kit Poon, CEO of ARBR. "We're excited to work with the team at Namaste to maximize the benefit from this relationship."
About Namaste Technologies
Namaste Technologies powers the ultimate online customer experience for medicinal cannabis and related products. Beginning with NamasteMD.com, the Company's integrated telemedicine application, Namaste connects medical clients with health care practitioners to more readily issue and renew cannabis prescriptions online. Featuring the first Canadian Medical Sales-Only Licence, the Company's own Cannmart.com is your 'everything cannabis store', offering clients a large variety of strains to fill their prescription needs. Namaste's unique artificial intelligence (AI) engine, incorporated into its platforms and related Uppy App, completes our ecosystem by identifying the right product and pairing to address specific medical cannabis requirements. Namaste also provides vaporizers and accessories across several platforms operating in multiple countries. Namaste's global technology addresses local needs in a burgeoning cannabis industry requiring smart solutions. For further information about Namaste, please visit www.Namastetechnologies.com.
ARBR is a clinician facing tool designed to provide medical cannabis recommendations on strains and dosing based on clinical evidence. For further information, please visit www.arbrlife.com
Information on the Company and its many products can be accessed through the links below:
FORWARD-LOOKING INFORMATION - This news release contains "forward-looking information" within the meaning of applicable securities laws. All statements contained herein that are not historical in nature contain forward-looking information. Forward-looking information can be identified by words or phrases such as "may", "expect", "likely", "should", "would", "plan", "anticipate", "intend", "potential", "proposed", "estimate", "believe" or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen. The forward-looking information contained herein is made as of the date of this press release and is based on assumptions management believed to be reasonable at the time such statements were made, including management's perceptions of future growth, results of operations, operational matters, historical trends, current conditions and expected future developments, as well as other considerations that are believed to be appropriate in the circumstances. While we consider these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct. By their nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release. Such factors include, without limitation: risks relating to the Company's ability to execute its business strategy and the benefits realizable therefrom, risks specifically related to the Company's international operations, and risks relating to the market price of the Common Shares. Additional risk factors can also be found in the Company's current MD&A and annual information form, both of which have been filed under the Company's SEDAR profile at www.sedar.com. Readers are cautioned not to put undue reliance on forward-looking information. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.
SOURCE Namaste Technologies Inc.
For further information: Incite Capital Markets, Eric Negraeff / Darren Seed, Ph: 604.493.2004; Meni Morim, Interim CEO Email: [email protected]